Akero Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.853; its P/E ratio is -7.64; Akero Therapeutics is scheduled to report earnings on May 14, 2024, and the estimated EPS forecast is $-0.94. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
EBIT	$ -53.51M	$ -39.03M	$ -30.50M	$ -25.39M	$ -22.66M
EBITDA	$ -57.04M	$ -42.17M	$ -31.75M	$ -26.55M	$ -22.75M
Net Income Common Stockholders	$ -54.64M	$ -39.91M	$ -31.08M	$ -25.85M	$ -23.02M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 550.01M	$ 554.73M	$ 639.44M	$ 343.22M	$ 351.45M
Total Assets	$ 580.27M	$ 635.33M	$ 663.81M	$ 348.78M	$ 356.57M
Total Debt	$ 25.78M	$ 25.73M	$ 25.68M	$ 25.63M	$ 10.62M
Net Debt	$ -524.23M	$ -529.00M	$ -613.76M	$ -317.59M	$ -340.83M
Total Liabilities	$ 44.97M	$ 52.20M	$ 47.37M	$ 42.47M	$ 30.01M
Stockholders Equity	$ 535.31M	$ 583.13M	$ 616.44M	$ 306.35M	$ 326.56M
Cash Flow	-
Free Cash Flow	$ -48.63M	$ -49.72M	$ -22.39M	$ -24.63M	$ -25.51M
Operating Cash Flow	$ -48.63M	$ -49.72M	$ -22.39M	$ -24.63M	$ -25.51M
Investing Cash Flow	$ 12.79M	$ -125.70M	$ -128.30M	$ 17.59M	$ -101.44M
Financing Cash Flow	$ 502.00K	$ 806.00K	$ 336.86M	$ 15.15M	$ 2.72M

Currency in USD

Akero Therapeutics Earnings and Revenue History

Income Statement >

Akero Therapeutics Debt to Assets

Balance Sheet >

Akero Therapeutics Cash Flow

Cash Flow >

Akero Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing